The 5-HT1 receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: Further involvement of 5-HT1F, but not 5-HT 1A or 5-HT1D, subtypes

European Journal of Pharmacology

Volumn 659, Issue 2-3, 2011, Pages 233-243

  González Hernández, Abimael ^a   Manrique Maldonado, Guadalupe ^a   Lozano Cuenca, Jair ^a   Muñoz Islas, Enriqueta ^a,c   Centurión, David ^a   Maassen VanDenBrink, Antoinette ^b   Villalón, Carlos M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Blood pressure; CGRP (calcitonin gene related peptide); LY344864; PNU 142633; Sumatriptan

Indexed keywords

1 [2 [4 [4 (AMINOCARBONYL)PHENYL] 1 PIPERAZINYL]ETHYL] 3,4 DIHYDRO N METHYL 1H 2 BENZOPYRAN 6 CARBOXAMIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; CALCITONIN GENE RELATED PEPTIDE; DIMETHYL SULFOXIDE; HEXAMETHONIUM; INDORENATE; METHOXAMINE; N (3 DIMETHYLAMINO 2,3,4,9 TETRAHYDRO 1H CARBAZOL 6 YL) 4 FLUOROBENZAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N,N DIPROPYL 5 CARBOXAMIDOTRYPTAMINE MALEATE; PNU 142633; SEROTONIN 1 RECEPTOR; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ELECTROSTIMULATION; HEMODYNAMICS; MALE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPINAL CORD STIMULATION; SPINAL GANGLION; STIMULUS RESPONSE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; ELECTRIC STIMULATION; HEMODYNAMICS; LIGANDS; MALE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; VASODILATION;

EID: 79955940223     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.035     Document Type: Article

References (32)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 90, 408-412.
2. 1B receptor cell line. Eur. J. Pharmacol. 360, 117-121.
3. Bell, D., McDermott, B.J., 1996. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho) physiological significance. Pharmacol. Rev. 48, 253-288.
4. Brain, S.D., Grant, A.D., 2004. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 84, 903-933.
5. Chen, J., Vasko, M.R., Wu, X., Staeva, T.P., Baez, M., Zgombick, J.M., Nelson, D.L., 1998. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J. Pharmacol. Exp. Ther. 287, 1119-1127.
6. 2 subtypes in rat vasculature in vitro and in vivo. Naunyn Schmiedeberg's Arch. Pharmacol. 326, 1-6.
7. Deng, P.Y., Li, Y.J., 2005. Calcitonin gene-related peptide and hypertension. Peptides 26, 1676-1685.
8. 1 receptors. Eur. J. Pharmacol. 237, 283-291.
9. Gillespie, J.S., MacLaren, A., Pollock, D., 1970. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br. J. Pharmacol. 40, 257-267.
10. 1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats. Eur. J. Pharmacol. 637, 131-137.
11. 1B receptors causes hypothermia in the guinea pig. Eur. J. Pharmacol. 331, 169-174.
12. Hoffman, B.B., 2001. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, In: Hardman, J.G., Limbird, L.E., Gilman, A.G. (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: USA, 10th Edition. , pp. 215-268.
13. Hoyer, D., 1989. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard, J.R. (Ed.), The Peripheral Actions of 5-Hydroxytryptamine. Oxford university press, UK, pp. 73-99.
14. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P., 1994. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203. (Pubitemid 24185150)
15. Kleinman, L., Radford, E., 1964. Ventilation standards for small mammals. J. Appl. Physiol. 19, 360-362.
16. 3H] alniditan. Mol. Pharmacol. 50, 1567-1580.
17. Lozano-Cuenca, J., González-Hernández, A., Muñoz-Islas, E., Sánchez-López, A., Centurión, D., Cobos-Puc, L.E., Villalón, C.M., 2009. Effect of some acute and prophylactic antimigraine drugs on the vasodepressor sensory CGRPergic outflow in pithed rats. Life Sci. 84, 125-131.
18. 4 receptor activation. Behav. Pharmacol. 20, 114-118.
19. Nicholson, R., Small, J., Dixon, A.K., Spanswick, D., Lee, K., 2003. Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci. Lett. 337, 119-122.
20. 1B receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 353, 144-156.
21. γS binding studies with stably transfected C6-glial cell line. Neuropharmacology 36, 499-512.
22. 1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. Life Sci. 61, 2117-2126.
23. 1D-selective ligands). Br. J. Pharmacol. 127, 468-472.
24. 1D receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 356, 312-320.
25. 1D subtypes. Naunyn Schmiedeberg's Arch. Pharmacol. 369, 220-227.
26. Taguchi, T., Kawasaki, H., Imamura, T., Takasaki, K., 1992. Endogenous calcitonin generelated peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rats. Circ. Res. 71, 357-364.
27. 1-adrenoceptors: an overview. Pharmacol. Rev. 45, 147-175.
28. 1A receptor ligands on the micturition reflex in rats: comparison with WAY 100635. J. Pharmacol. Exp. Ther. 290, 1258-1269.
29. Villalón, C.M., Centurión, D., 2007. Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn Schmiedeberg's Arch. Pharmacol. 376, 45-63.
30. 1D subtypes. Br. J. Pharmacol. 124, 1001-1011.
31. 2A/2C)- adrenoceptors. Br. J. Pharmacol. 154, 51-59.
32. γS binding: correlation with inhibition of guinea pig dural plasma protein extravasation. Eur. J. Pharmacol. 352, 117-124.